EGFR is not only abnormally expressed in cervical cancer, but also overexpressed in ovarian cancer, and downregulation of EGFR expression inhibits ovarian cancer cell proliferation (Dou et al., 2021). This evidence concerns the gene EGFR and ovarian carcinoma.